Validating artificial intelligence effectiveness defined Lung nodule malignancy score in patients with pulmonary nodule.

Trial Identifier:	D133FR00178
Sponsor:	AstraZeneca
NCTID:	NCT05817110
Start Date:	April 2023
Primary Completion Date:	April 2026
Study Completion Date:	April 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.